AnchorChartPRO’s All-in-One EdTech Solution Now Live Columbus, United States – January 1, 2026 / AnchorChartPRO / AnchorChartPRO, an innovative education technology startup headquartered in Columbus, ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback